Etidronate Disodium (Mylan Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Etidronate Disodium drug offered from Mylan Pharmaceuticals Inc.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Pharmaceuticals Inc.
NON-PROPRIETARY NAME: etidronate disodium
SUBSTANCE NAME: ETIDRONATE DISODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2008-01-02
END MARKETING DATE: 2019-11-30


Etidronate Disodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEtidronate Disodium from Mylan Pharmaceuticals Inc.
LABELER NAME: Mylan Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 2008-01-02
END MARKETING DATE: 2019-11-30
PRODUCT ID: 0378-3286_1c3be377-d59d-4424-b7bd-649e3133b8cd
PRODUCT NDC: 0378-3286
APPLICATION NUMBER: ANDA075800

Other ETIDRONATE DISODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Carilion Materials ManagementEtidronate Disodium
Mylan Pharmaceuticals Inc.Etidronate Disodium